MPS Limited has informed the Exchange regarding Change in Auditors of the company.
MPSLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
MPS Limited held its Board Meeting on 15 May 2026 and approved the audited Q4 and FY2026 financial results. Standalone total income for the year was INR 37,293 lakhs with net profit after tax of INR 13,126 lakhs, up from INR 11,116 lakhs in the previous year. The Board decided NOT to recommend a final dividend for FY2025-26, citing that capital was deployed towards the acquisition of Unbound Medicine, Inc. completed on 9 February 2026. The company appointed KPMG Assurance and Consulting Services LLP as the new Internal Auditors for a 3-year term from FY2026-27 to FY2028-29. Separately, the Board approved the re-appointment of existing statutory auditors Walker Chandiok & Co LLP for a second 5-year term, subject to shareholder approval at the ensuing AGM.
The appointment of KPMG as new internal auditors represents a change in audit oversight, while the retention of capital for acquisitions rather than paying dividends signals continued investment focus. Shareholders should note no dividend is expected for FY2025-26.